Management and therapy of vasovagal syncope: A review  

作　　者：Muhammet Ali Aydin Tushar V Salukhe Iris Wilke Stephan Willems 

机构地区：[1]Department of Electrophysiology, University Heart Center Hamburg

出　　处：《World Journal of Cardiology》2010年第10期308-315,共8页世界心脏病学杂志（英文版）（电子版）

摘　　要：Vasovagal syncope is a common cause of recurrent syncope. Clinically, these episodes may present as an isolated event with an identifiable trigger, or manifest as a cluster of recurrent episodes warranting intensive evaluation. The mechanism of vasovagal syncope is incompletely understood. Diagnostic tools such as implantable loop recorders may facilitate the identification of patients with arrhythmia mimicking benign vasovagal syncope. This review focuses on the management of vasovagal syncope and discusses the non-pharmacological and pharmacological treatment options, especially the use of midodrine and selective serotonin reuptake inhibitors. The role of cardiac pacing may be meaningful for a subgroup of patients who manifest severe bradycardia or asystole but this still remains controversial.Vasovagal syncope is a common cause of recurrent syncope. Clinically, these episodes may present as an isolated event with an identifiable trigger, or manifest as a cluster of recurrent episodes warranting intensive evaluation. The mechanism of vasovagal syncope is incompletely understood. Diagnostic tools such as implantable loop recorders may facilitate the identification of patients with arrhythmia mimicking benign vasovagal syncope. This review focuses on the management of vasovagal syncope and discusses the non-pharmacological and pharmacological treatment options, especially the use of midodrine and selective serotonin reuptake inhibitors. The role of cardiac pacing may be meaningful for a subgroup of patients who manifest severe bradycardia or asystole but this still remains controversial.

关 键 词：VASOVAGAL SYNCOPE Midodrine ADRENERGIC β-antagonists SEROTONIN uptake inhibitors 

分 类 号：R725.4[医药卫生—儿科]